Correlation Between Enliven Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Enliven Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Enliven Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Enliven Therapeutics and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Enliven Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Enliven Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Enliven Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Enliven Therapeutics and Milestone Pharmaceuticals
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Enliven and Milestone is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Enliven Therapeutics and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Enliven Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Enliven Therapeutics are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Enliven Therapeutics i.e., Enliven Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Enliven Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Enliven Therapeutics is expected to generate 1.07 times more return on investment than Milestone Pharmaceuticals. However, Enliven Therapeutics is 1.07 times more volatile than Milestone Pharmaceuticals. It trades about 0.04 of its potential returns per unit of risk. Milestone Pharmaceuticals is currently generating about -0.01 per unit of risk. If you would invest 1,772 in Enliven Therapeutics on September 3, 2024 and sell it today you would earn a total of 666.00 from holding Enliven Therapeutics or generate 37.58% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Enliven Therapeutics vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Enliven Therapeutics |
| Milestone Pharmaceuticals |
Enliven Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Enliven Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Enliven Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Enliven Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Enliven Therapeutics vs. DiaMedica Therapeutics | Enliven Therapeutics vs. Lyra Therapeutics | Enliven Therapeutics vs. Centessa Pharmaceuticals PLC |
| Milestone Pharmaceuticals vs. DiaMedica Therapeutics | Milestone Pharmaceuticals vs. Lyra Therapeutics | Milestone Pharmaceuticals vs. Centessa Pharmaceuticals PLC |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Other Complementary Tools
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |